839
Views
6
CrossRef citations to date
0
Altmetric
Original Articles

Efficacy and safety of tranexamic acid in acute upper gastrointestinal bleeding: meta-analysis of randomised controlled trials

, , , , ORCID Icon, , , ORCID Icon, , , & show all
Pages 1390-1397 | Received 21 Sep 2020, Accepted 16 Oct 2020, Published online: 28 Oct 2020

References

  • Hearnshaw SA, Logan RF, Lowe D, et al. Acute upper gastrointestinal bleeding in the UK: patient characteristics, diagnoses and outcomes in the 2007 UK audit. Gut 2011;60(10):1327–1335.
  • Wilcox CM, Cryer BL, Henk HJ, et al. Mortality associated with gastrointestinal bleeding events: Comparing short-term clinical outcomes of patients hospitalized for upper GI bleeding and acute myocardial infarction in a US managed care setting. Clin Exp Gastroenterol. 2009;2:21–30.
  • Laine L, Peterson WL. Bleeding peptic ulcer. N Engl J Med. 1994;331(11):717–727.
  • Cox HT, Poller L, Thomson JM. Evidence for the release of gastric fibrinolytic activity into peripheral blood. Gut 1969;10(5):404–407.
  • Cox HT, Poller L, Thomson JM. Gastric fibrinolysis. A possible aetiological link with peptic ulcer. Lancet 1967;1(7503):1300–1302.
  • Faught C, Wells P, Fergusson D, et al. Adverse effects of methods for minimizing perioperative allogeneic transfusion: a critical review of the literature. Transfus Med Rev. 1998;12(3):206–225.
  • McCormack PL. Tranexamic acid: a review of its use in the treatment of hyperfibrinolysis. Drugs. 2012;72(5):585–617.
  • Bennett C, Klingenberg SL, Langholz E, et al. Tranexamic acid for upper gastrointestinal bleeding. Cochrane Database Syst Rev. 2014;(11):CD006640.
  • Twum-Barimah E, Abdelgadir I, Gordon M, et al. Systematic review with meta-analysis: the efficacy of tranexamic acid in upper gastrointestinal bleeding. Aliment Pharmacol Ther. 2020;51(11):1004–1013.
  • Roberts I, Shakur-Still H, Afolabi A, et al. Effects of a high-dose 24-h infusion of tranexamic acid on death and thromboembolic events in patients with acute gastrointestinal bleeding (HALT-IT): An international randomised, double-blind, placebo-controlled trial. Lancet 2020;395(10241):1927–1936.
  • Tavakoli N, Mokhtare M, Agah S, et al. Comparison of the efficacy of intravenous tranexamic acid with and without topical administration versus placebo in urgent endoscopy rate for acute gastrointestinal bleeding: a double-blind randomized controlled trial. United Eur Gastroenterol J. 2018;6(1):46–54.
  • Karadaş A, Doğan N, Pinar SG, et al. A randomized controlled trial of the effects of local tranexamic acid on mortality, rebleeding, and recurrent endoscopy need in patients with upper gastrointestinal hemorrhage. Eur J Gastroenterol Hepatol. 2020;32(1):26–31.
  • Saidi H, Shojaie S, Ghavami Y, et al. Role of intra-gastric tranexamic acid in management of acute upper gastrointestinal bleeding. Iioab J. 2017;8(1):76–81.
  • Bagnenko SF, Verbitskiĭ VG. Antifibrinolitic therapy for the treatment of massive ulcerative gastro-intestinal bleedings. Khirurgiia (Mosk). 2011;(4):42–46.
  • Hawkey GM, Cole AT, McIntyre AS, et al. Drug treatments in upper gastrointestinal bleeding: value of endoscopic findings as surrogate end points. Gut 2001;49(3):372–379.
  • von Holstein CC, Eriksson SB, Källén R. Tranexamic acid as an aid to reducing blood transfusion requirements in gastric and duodenal bleeding. Br Med J (Clin Res Ed). 1987;294(6563):7–10.
  • Barer D, Ogilvie A, Henry D, et al. Cimetidine and tranexamic acid in the treatment of acute upper-gastrointestinal-tract bleeding. N Engl J Med. 1983;308(26):1571–1575.
  • Bergqvist D, Dahlgren S, Hessman Y. Local inhibition of the fibrinolytic system in patients with massive upper gastrointestinal hemorrhage. Ups J Med Sci. 1980;85(2):173–178.
  • Engqvist A, Broström O, von Feilitzen F, et al. Tranexamic acid in massive haemorrhage from the upper gastrointestinal tract: a double-blind study. Scand J Gastroenterol. 1979;14(7):839–844.
  • Biggs JC, Hugh TB, Dodds AJ. Tranexamic acid and upper gastrointestinal haemorrhage-A double-blind trial. Gut. 1976;17(9):729–734.
  • Cormack F, Chakrabarti RR, Jouhar AJ, et al. Tranexamic acid in upper gastrointestinal haemorrhage. Lancet 1973;1(7814):1207–1208.
  • Laine L, Jensen DM. Management of patients with ulcer bleeding. Am J Gastroenterol. 2012;107(3):345–360. quiz 61.
  • Acute upper gastrointestinal bleeding in over 16s: Management. London: National Institute for Health and Care Excellence: Clinical Guidelines; 2016.
  • Coats TJ, Morsy M. Biological mechanisms and individual variation in fibrinolysis after major trauma. Emerg Med J. 2020;37(3):135–140.
  • Raza I, Davenport R, Rourke C, et al. The incidence and magnitude of fibrinolytic activation in trauma patients. J Thromb Haemost. 2013;11(2):307–314.
  • Roberts I, Shakur H, Coats T, et al. The CRASH-2 trial: a randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion requirement in bleeding trauma patients. Health Technol Assess. 2013;17(10):1–79.
  • Faraoni D, Schaefer ST. Randomized controlled trials vs. observational studies: why not just live together? BMC Anesthesiol. 2016;16(1):102.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.